Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Mark Yarema"'
Publikováno v:
Case Reports in Critical Care, Vol 2021 (2021)
Externí odkaz:
https://doaj.org/article/55abd50e12e14ebeb8f0822edb5bc461
Publikováno v:
Case Reports in Critical Care, Vol 2021 (2021)
Acetaminophen overdose is one of the most common causes of acute hepatic failure in the developed world. There is strong evidence for N-acetylcysteine (NAC) as a safe and effective antidote for acetaminophen toxicity. However, there is less clarity i
Externí odkaz:
https://doaj.org/article/c4570fac03b846cb9f87072f511398d9
Publikováno v:
Clinical Toxicology. 60:1113-1121
The introduction of delayed release formulations of acetaminophen (APAP) has created concern about the role of formulation in overdose. We examined the APAP overdose pharmacokinetic (PK) profiles to assess the role of dose, coingestants and formulati
Autor:
Chris DeWitt, Marco L.A. Sivilotti, Elizabeth Haney, Margaret Thompson, David W. Johnson, Charlemagne Victorino, Sophie Gosselin, Jason A Lord, Barry H. Rumack, Benoit Bailey, Daniel A. Spyker, Roy Purssell, Nancy G. Murphy, Kathryn Dong, Alberto Nettel-Aguirre, Mark Yarema
Publikováno v:
British Journal of Clinical Pharmacology. 87:3332-3343
Aims Early identification of patients likely to die after acetaminophen (APAP) poisoning remains challenging. We sought to compare the sensitivity and time to fulfilment (latency) of established prognostic criteria. Methods Three physician toxicologi
Autor:
Marco L.A. Sivilotti, Scott N. Lucyk, Mark Yarema, David W Johnson, Ryan Chuang, Joanne Masur, Katie Y. Lin, Yang Steven Liu, Shalyn Barby
Publikováno v:
The Journal of Emergency Medicine. 58:910-916
Background Relying on a treatment threshold for methanol poisoning of 20 mg/dL (6.2 mmol/L) as a stand-alone criterion may lead to unnecessary and invasive treatment because it is likely too conservative, especially for patients with repeated, intent
Publikováno v:
Clinical toxicology (Philadelphia, Pa.). 60(4)
Some studies have reported that early administration of acetylcysteine using a 3-bag regimen may not fully prevent development of liver injury in some patients. We compared the incidence of acute liver injury (ALI) in patients receiving acetylcystein
Autor:
Barry H. Rumack, Jason P Green, Adam Mutsaers, Marco L.A. Sivilotti, Mark Yarema, David W Johnson
Publikováno v:
Clinical toxicology (Philadelphia, Pa.). 58(3)
To the Editor,We would like to thank the authors for their correspondence.Given the retrospective design and limited clinical variables as acknowledged in the manuscript, our study does not definit...
Anaphylactoid Reactions to Intravenous N-Acetylcysteine during Treatment for Acetaminophen Poisoning
Autor:
Charlemaigne Victorino, Sophie Gosselin, Benoit Bailey, David W. Johnson, Alberto Nettel-Aguirre, Daniel A. Spyker, Marco L.A. Sivilotti, Margaret Thompson, Roy Purssell, Mark Yarema, Barry H. Rumack, Puja Chopra
Publikováno v:
Journal of Medical Toxicology. 14:120-127
Anaphylactoid reactions to intravenous (IV) N-acetylcysteine (NAC) are well-recognized adverse events during treatment for acetaminophen (APAP) poisoning. Uncertainty exists regarding their incidence, severity, risk factors, and management. We sought
Autor:
Marco L.A. Sivilotti, Michael C. Beuhler, D. Adam Algren, Margaret Thompson, Mark Yarema, Christopher P. Holstege, Michael E. Mullins
Publikováno v:
Clinical Toxicology. 58:433-435
Dear Editor,We agree with Hoyte and Dart that the three-bag Prescott protocol for acetylcysteine is overdue for improvement [1]. We also agree that the key steps in transitioning to a new protocol ...
Publikováno v:
Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 150:259-268
Objective: To evaluate pharmacists’ attitudes toward the Take Home Naloxone (THN) program and identify areas that could be improved to support pharmacists’ involvement. Methods: Pharmacists on the Alberta College of Pharmacists’ directory were